[HTML][HTML] Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali… - Stem cell research & …, 2021 - Springer
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

[PDF][PDF] Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali, A Abdel‑Latif… - 2021 - researchgate.net
Abstract Novel coronavirus disease 2019 (COVID‑19) is caused by severe acute respiratory
syndrome coronavirus‑2. The virus causes an exaggerated immune response, resulting in a …

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali, A Abdel-Latif… - 2021 - agris.fao.org
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.

M Abdelgawad, NS Bakry, AA Farghali… - Stem Cell Research …, 2021 - search.ebscohost.com
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

[HTML][HTML] Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry… - … Cell Research & …, 2021 - stemcellres.biomedcentral.com
Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

[HTML][HTML] Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali… - Stem Cell Research & …, 2021 - ncbi.nlm.nih.gov
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.

M Abdelgawad, NS Bakry, AA Farghali… - Stem Cell Research & …, 2021 - go.gale.com
Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

[PDF][PDF] Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali, A Abdel‑Latif… - 2021 - scholar.archive.org
Abstract Novel coronavirus disease 2019 (COVID‑19) is caused by severe acute respiratory
syndrome coronavirus‑2. The virus causes an exaggerated immune response, resulting in a …

[PDF][PDF] Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali, A Abdel-Latif… - 2021 - academia.edu
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry… - Stem cell research …, 2021 - pubmed.ncbi.nlm.nih.gov
Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …